EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TargetSA: adaptive simulated annealing for target-specific drug design

Zhe Xue iD, Chenwei Sun, Wenhao Zheng, Jiancheng Lv, Xianggen Liu iD

Bioinformatics · 26.12.2024 · 41 (1)

DOI: 10.1093/bioinformatics/btae730 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformatics, online erschienen am 04.12.2024. Verfasst von Zhe Xue und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Computer Science, Sichuan University, Chengdu, Sichuan 610065, China. Hauptthemen laut MEDLINE: Drug Design. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province, Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Motivation The burgeoning field of target-specific drug design has attracted considerable attention, focusing on identifying compounds with high binding affinity toward specific target pockets. Nevertheless, existing target-specific deep generative models encounter notable challenges. Some models heavily rely on elaborate datasets and complicated training methodologies, while others neglect the multi-constraint optimization problem inherent in drug design, resulting in generated molecules with irrational structures or chemical properties. Results To address these issues, we propose a novel framework (TargetSA) that leverages adaptive simulated annealing (SA) for target-specific molecular generation and multi-constraint optimization. The SA process explores the discrete structural space of molecules, progressively converging toward the optimal solution that fulfills the predefined objective. To propose novel compounds, we first predict promising editing positions based on historical experience, and then iteratively edit molecular graphs through four operations (insertion, replacement, deletion, and cyclization). Together, these operations collectively constitute a complete operation set, facilitating a thorough exploration of the drug-like space. Furthermore, we introduce a reversible sampling strategy to re-accept currently suboptimal solutions, greatly enhancing the generation quality. Empirical evaluations demonstrate that TargetSA achieves state-of-the-art performance in generating high-affinity molecules (average vina dock −9.09) while maintaining desirable chemical properties. Availability and implementation https://github.com/XueZhe-Zachary/TargetSA

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DesignAlgorithmsSoftware

Autor:innen und Institutionen

  • College of Computer Science, Sichuan University, Chengdu, Sichuan 610065, China.
  • Laboratory of Anesthesia and Critical Care Medicine, Department of Anesthesiology, Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.

ORCID-Profile: Zhe Xue, Xianggen Liu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Sichuan Province
  • Central Universities

Zitieren

APA

Xue, Z., Sun, C., Zheng, W., Lv, J., & Liu, X. (2024). TargetSA: adaptive simulated annealing for target-specific drug design. Bioinformatics, 41(1). https://doi.org/10.1093/bioinformatics/btae730

Vancouver

Xue Z, Sun C, Zheng W, Lv J, Liu X. TargetSA: adaptive simulated annealing for target-specific drug design. Bioinformatics. 2024;41(1). doi:10.1093/bioinformatics/btae730

BibTeX
@article{Xue2024,
  author = {Xue, Zhe and Sun, Chenwei and Zheng, Wenhao and Lv, Jiancheng and Liu, Xianggen},
  title = {TargetSA: adaptive simulated annealing for target-specific drug design},
  journal = {Bioinformatics},
  year = {2024},
  volume = {41},
  number = {1},
  doi = {10.1093/bioinformatics/btae730}
}
Kostenlos starten →